APA (7th ed.) Citation

Ka Man Yip, Kwan Ming Lee, Tzi Bun Ng, Shujun Xu, Ken Kin Lam Yung, Shaogang Qu, . . . Stephen Cho Wing Sze. (2022). An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding. BMC.

Chicago Style (17th ed.) Citation

Ka Man Yip, Kwan Ming Lee, Tzi Bun Ng, Shujun Xu, Ken Kin Lam Yung, Shaogang Qu, Allen Ka Loon Cheung, and Stephen Cho Wing Sze. An Anti-inflammatory and Anti-fibrotic Proprietary Chinese Medicine Nasal Spray Designated as Allergic Rhinitis Nose Drops (ARND) with Potential to Prevent SARS-CoV-2 Coronavirus Infection by Targeting RBD (Delta)- Angiotensin Converting Enzyme 2 (ACE2) Binding. BMC, 2022.

MLA (9th ed.) Citation

Ka Man Yip, et al. An Anti-inflammatory and Anti-fibrotic Proprietary Chinese Medicine Nasal Spray Designated as Allergic Rhinitis Nose Drops (ARND) with Potential to Prevent SARS-CoV-2 Coronavirus Infection by Targeting RBD (Delta)- Angiotensin Converting Enzyme 2 (ACE2) Binding. BMC, 2022.